Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.22.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenue, Major Customer [Line Items]        
Revenues $ 13,028,394 $ 13,340,487 $ 27,163,526 $ 27,957,476
FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 13,028,394 13,340,487 27,163,526 27,094,645
PREBOOST Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues       862,831
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 11,590,466 10,312,742 23,164,732 19,414,481
Global Public Health Sector [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues $ 1,437,928 $ 3,027,745 $ 3,998,794 $ 7,680,164